NEUPOGEN 30 MU (0,3 mg/mL), solution injectable

Business Listing - September 04, 2021

NEUPOGEN 30 MU (0,3 mg/mL), solution injectable

NEUPOGEN 30 MU (0,3 mg/mL), solution injectable solution injectable intraveineuse;sous-cutanée Autorisation active Procédure de reconnaissance mutuelle Commercialisée 7/15/1991 AMGEN EUROPE

Tags & Categories

intraveineuse active solution injectable autorisation procédure cutanée reconnaissance mutuelle neupogen

Featured

This is a premium business listing. Stand out from the competition!

Own a Business?

List your company and reach more customers today.

Add Your Business